Varicella zoster virus vaccine live - El-Shaddai

Drug Profile

Varicella zoster virus vaccine live - El-Shaddai

Alternative Names: Chickenpox vaccine - El-Shaddai

Latest Information Update: 03 Jun 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator El-Shaddai Biologicals
  • Class Varicella vaccines; Viruses
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Varicella zoster virus infections

Most Recent Events

  • 03 Jun 2015 No recent reports on development identified - Phase-III for Varicella zoster virus infections (In children, In infants, Prevention) in India (SC)
  • 22 Dec 2011 El-Shaddai completes a phase III trial in Varicella zoster virus infections (prevention, in children and infants) in India (CTRI/2011/06/001787)
  • 15 Jun 2011 Phase-III clinical trials in Varicella zoster virus infections (prevention, in children and infants) in India (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top